The addition of nivolumab to neoadjuvant chemotherapy significantly increased pathologic complete response among certain ...
Recent studies have explored combining new therapies, such as PD-1 inhibitors like nivolumab, with chemotherapy to potentially improve long-term outcomes. 2,3 Notably, research from the University ...
Seven-year follow-up data of a multicenter, randomized phase 2 study evaluating the treatment of melanoma brain metastases shows ipilimumab plus nivolumab is an effective long-term care option. First ...
Progression-free survival was significantly greater in the nivolumab plus ipilimumab group compared to nivolumab alone. 2. Treatment-related adverse events were slightly higher in nivolumab plus ...
Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results